Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-01-27

Clinical Trial Update: Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ablation versus medical therapy for ventricular tachycardia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Newmarket Electrophysiology Research Group Inc | Conditions: Ventricular Tachycardia, Coronary Artery Disease | Phase 3 | Status: WITHDRAWN